Uaktualnienie wytycznych ADA/EASD na temat leczenia cukrzycy typu 2

Silvio E. Inzucchi i wsp. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes , LINK: Diabetes Care January 2015;38:140 (dostępny pełen tekst)

Glucose control remains a major focus in the management of patients with type 2 diabetes. However, this should always be in the context of a comprehensive cardiovascular risk factor reduction program, to include smoking cessation and the adoption of other healthy lifestyle habits, blood pressure control, lipid management with priority to statin medications, and, in some circumstances, antiplatelet therapy. Studies have conclusively determined that reducing hyperglycemia decreases the onset and progression of microvascular complications. The impact of glucose control on cardiovascular complications remains uncertain; a more modest benefit is likely to be present, but probably emerges only after many years ofimproved control

Opracowane na podstawie: Diabetes Care / styczeń 2015

0 replies on “Uaktualnienie wytycznych ADA/EASD na temat leczenia cukrzycy typu 2”